StockDriftsStockDriftsTop 50 Birchview Capital LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| KLAC | KLA CORPORATION | 25.18% | 178.5K | $53.8M | -10.24%(-20.36K) | $84.05(+136.27%) | 2026-06-30 | |
| BMY | BRISTOL-MYERS SQUIBB CO | 8.01% | 297.2K | $17.1M | -2.95%(-9.03K) | $57.18(+13.03%) | 2026-06-30 | |
| LRCX | LAM RESEARCH CORPORATION | 7.09% | 35.0K | $15.2M | -2.78%(-1.00K) | $152.54(+121.19%) | 2026-06-30 | |
| NTLA | INTELLIA THERAPEUTICS INC (NTLA) C @ 13.0 10/16/2026 | 3.17% | 385.9K | $6.8M | -13.36%(-59.50K) | $11.89(+0.19%) | 2026-06-30 | |
| SLDB | SOLID BIOSCIENCES INC | 3.11% | 666.2K | $6.7M | +6.42%(+40.22K) | $5.55(+65.89%) | 2026-06-30 | |
| BDS | BIODESIX INC | 3.02% | 286.8K | $6.5M | +0.00%(+0) | $5.56 | 2026-06-30 | |
| STOK | STOKE THERAPEUTICS INC | 2.73% | 178.1K | $5.8M | -15.19%(-31.89K) | $12.96(+141.34%) | 2026-06-30 | |
| OVV | OVINTIV INC | 2.65% | 107.5K | $5.7M | +0.00%(+0) | $38.64(+63.47%) | 2026-06-30 | |
| NKTR | NEKTAR THERAPEUTICS | 2.64% | 81.0K | $5.7M | +161.29%(+50.00K) | $60.26(+22.58%) | 2026-06-30 | |
| CORT | CORCEPT THERAPEUTICS INC | 2.33% | 57.2K | $5.0M | +21.19%(+10.00K) | $23.31(+391.16%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +10.21% | +33.86% | -1.20% | -5.88% |
| Top 20 Holdings Unweighted | +15.93% | +55.80% | +5.51% | +30.76% |
Birchview Capital LP reports $213.83M in US-listed equity holdings across 72 positions in its most recent 13F filing. Its largest disclosed positions are KLAC (25.2%), BMY (8.0%) and LRCX (7.1%). The top 20 holdings account for 76.07% of reported assets. Its disclosed equity book has returned +33.86% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Birchview Capital LP, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Birchview Capital LP’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1618205). View Birchview Capital LP’s 13F filings on SEC